Upgrade to SI Premium - Free Trial

Puma Biotech (PBYI) Surges Following Results; Analyst Sees Few Excuses Not to Own

March 1, 2019 10:51 AM
Puma Biotech (NASDAQ: PBYI) pushes to highs following earnings after the close. Shares are up 42% on volume that ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Momentum Movers Trader Talk

Next Articles